Reaction

Borderline Personality Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 700 reports · 20 co-occurring drugs

As of the last recalculation, Borderline Personality Disorder appears in 700 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is ZIPRASIDONE MESYLATE (PRR 29.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ziprasidone Mesylate1429.829.8
Calcium, Magnesium, Potassium, And Sodium Oxybates827.928.0
Haloperidol2227.827.8
Haloperidol Lactate2227.227.3
Ziprasidone1424.124.1
Nicotine Polacrilex Mini1122.122.1
Nicotine Polarilex1122.122.1
Lithium Carbonate1221.421.4
Lithium1720.520.5
Lithium Bromatum1720.520.5
Lurasidone Hydrochloride1420.320.3
Asenapine Maleate413.813.8
Clozapine5213.213.2
Brexpiprazole712.712.7
Buprenorphine Hydrochloride, Naloxone Hydrochloride1012.512.5
Sodium Oxybate2612.112.1
Hydrocodone Bitartrate And Acetaminophen168.68.6
Elexacaftor, Tezacaftor, And Ivacaftor37.27.2
Esketamine Hydrochloride46.76.7
Valbenazine33.63.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.